Yahoo Web Search

  • FirefoxTry Yahoo Search on Firefox »
    1. Yahoo Finance Results

    2. Edited Transcript of PPHM earnings conference call or presentation 11-Sep-17 8:30pm GMT

      Thomson Reuters StreetEvents via Yahoo FinanceSep 12 23:51 PM

      Lytle Peregrine Pharmaceuticals, Inc. - CFO * Roger Lias * Steven W. King Peregrine Pharmaceuticals, Inc. - President, CEO & Director * Tim Brons ========= ...

    3. (PPHM) (PPHMP), a biopharmaceutical company committed to improving patient lives by manufacturing high quality...success in the CDMO industry, and was an ideal candidate for the position,” stated ...

    4. (PPHM) (PPHMP), a biopharmaceutical company committed to improving patient lives by manufacturing high quality...will also join Peregrine’s board of directors. In conjunction with this appointment ...

    5. Own Alphabet Inc. Stock? Antitrust Is on the Horizon

      InvestorPlace via Yahoo FinanceSep 15 12:26 PM

      Case in point: Take a look at how a Senate Committee came down on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) last year, claiming that unmerited price increases on many of its ...

    6. symbol=AMPH Metaxalone The USP 800 mg Metaxalone tablets, launched in the American market are a generic version of King Pharmaceuticals Research and Development Inc.'s Skelaxin ...

    7. SOFT - Stock Ticker Symbol Up For Sale

      PR Newswire via Yahoo FinanceSep 14 8:00 AM

      Website - www.modernip.com Jack Hazan Executive Vice President Hilco Streambank (212) 610-5663 jhazan@hilcoglobal.com Cyntia King Founder Modern IP (818) 209-6088 cking@modernip.com Dmitriy ...

    8. Skelaxin® is a trademark of King Pharmaceuticals Research and Development, Inc. *IMS National Sales Perspective: Retail and Non-Retail MAT July 2017 RDY-0617-168 About Dr ...

    9. 5 Ways To Play The Biotech Bull Market

      Oilprice.com via Yahoo FinanceSep 11 23:30 PM

      (Click to enlarge) #5 Gilead Sciences, Inc. (NASDAQ:GILD) Market Cap: $109.38 billion Gilead has seen growth of an impressive 30... the first week of September, Gilead finally puts its ...

    10. Carter served as chief scientific officer, head of research and development, and chief medical officer of King Pharmaceuticals from 2007 until the company was acquired by Pfizer ...

    11. PharmaJet’s devices are also integral in the development of multiple novel pharmaceuticals. The innovative Stratis® device has U.S. FDA 510(k) marketing clearance...1. AFLURIA QUADRIVALENT ...